News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Biotech Bay
Anacor Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
February 24, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals announced today that David Perry, the company’s Chief Executive Officer, will provide a company overview at the following investor conferences in March:
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Pancreatic cancer
Revolution’s second RAS blocker doubles chemo response rate in pancreatic cancer
June 25, 2026
·
2 min read
·
Tristan Manalac
Podcast
AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more
June 24, 2026
·
1 min read
·
Jef Akst
Antibody-drug conjugate
Can ADCs be kinder and gentler? Join
BioSpace
at BIO to find out
June 23, 2026
·
3 min read
·
Annalee Armstrong
Drug pricing
BIO 2026: Biopharma dealmakers seek to protect ‘premium pricing’ from Trump’s MFN policy
June 23, 2026
·
2 min read
·
Annalee Armstrong
